CAR T

FDA approves BMS’ multiple myeloma CAR-T Abecma

https://pharmaphorum.com/news/fda-approves-bms-multiple-myeloma-car-t-abecma/

Lymphoma Action – championing the patient voice in cell therapy

https://pharmaphorum.com/market-access-2/lymphoma-action-championing-the-patient-voice-in-cell-therapy/

NHS and Kite sign access deal for Kite’s cancer cell therapy Tecartus

https://pharmaphorum.com/news/nhs-kite-cancer-therapy/

Why cell therapy manufacture is a team sport

https://pharmaphorum.com/market-access-2/why-cell-therapy-manufacture-is-a-team-sport/

Welcome to the CAR-TCR Summit Europe 2021

https://pharmaphorum.com/events/welcome-to-the-car-tcr-summit-europe-2021/

Cellular Immunotherapies for Solid Tumors Summit

https://pharmaphorum.com/events/cellular-immunotherapies-for-solid-tumors-summit/

CAR-T Beyond Oncology Digital Summit

https://pharmaphorum.com/events/car-t-beyond-oncology-digital-summit/

FDA’s review date for BMS’ ide-cel sneaks under the CVR wire

https://pharmaphorum.com/news/fdas-review-date-for-bms-ide-cel-sneaks-under-the-cvr-wire/

Preparing for an influx of cell and gene therapy approvals

https://pharmaphorum.com/views-analysis-sales-marketing/preparing-influx-cell-gene-therapy-approvals/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search